Why Joby Aviation's Move Into Defense Is a Bullish Sign for Investors

Joby Aviation plans to acquire Resonant Sciences for $500 million ($450 million cash and $50 million in common stock), a move intended to deepen its defense presence while keeping focus on commercial air taxis. Resonant generated more than $100 million in trailing-12-month revenue and grew revenue ~40% YoY, potentially accelerating Joby’s defense business despite the near-term cost. The stock fell in the short term on valuation trade-offs, but the article frames the dip as an opportunity amid expected volatility as air taxi regulation and mass adoption remain years away.

Analysis

The strategic question is not whether JOBY can buy revenue; it is whether it can buy a defensible second leg that is credibly accretive to valuation. Defense can support a higher multiple only if it becomes recurring, software- or systems-heavy, and less capital intensive than the core air-taxi thesis; otherwise the market will treat this as a cash-consuming diversification move with limited near-term earnings impact.

In the next 1-3 months, the stock should trade on balance-sheet math and backlog disclosure, not on the headline strategic narrative. A meaningful cash outlay for a pre-profit company raises the probability of future dilution, and that is the part that can overpower any “strategic” premium. Second-order, the better-positioned winners are established autonomy/defense names with existing procurement channels and execution history, including KTOS and AVAV; they can absorb defense demand without distracting from a speculative consumer-aviation roadmap.

The contrarian case is that the market may still be valuing JOBY as a pure eVTOL option, while management is building a dual-use platform that could be less binary than certification alone. But that view is only valid if defense contracts convert quickly and margins are real; if contract wins remain sporadic, the acquisition will likely be seen as expensive empire-building. The key falsifier over 6-18 months is whether management can show durable defense revenue and an unchanged runway after integration costs; if not, this remains a financing story, not a re-rating story.

Key Decisions for Investors

• Do not chase JOBY on the strategic narrative alone; wait for post-close disclosure on cash runway, integration cost, and defense backlog before adding exposure.
• If expressing a relative-value view, favor long KTOS or AVAV versus short JOBY over the next 1-3 months: established defense autonomy platforms have clearer revenue conversion and lower dilution risk.
• Use any sharp relief rally in JOBY to sell a short-dated call spread or trim exposure unless management provides contract visibility that covers a meaningful portion of the acquisition cost within 2 quarters.
• Set a watch item on JOBY’s next update: if defense backlog/ARR does not clearly inflect and cash burn worsens, treat the acquisition as multiple-negative and avoid adding for 6-12 months.